क्यूआर कोड

Successful Crizotinib Rechallenge after Crizotinib-Induced Organizing Pneumonia in Anaplastic Lymphoma Kinase-Rearranged Non-Small Cell Lung Cancer

Crizotinib, a first-line anaplastic lymphoma kinase (ALK)-tyrosine kinase inhibitor, has shown promising results for the treatment of locally advanced and metastatic lung cancer presenting the ALK rearrangement. On the other hand, secondary organizing pneumonia (OP) caused by anti-cancer drugs has b...

पूर्ण विवरण

में बचाया:
मुख्य लेखकों: Nobuhiro Asai, Toyoharu Yokoi, Etsuro Yamaguchi, Akihito Kubo
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Karger Publishers 2014-09-01
श्रृंखला:Case Reports in Oncology
विषय:
Lung cancer
Crizotinib
Organizing pneumonia
EML4-ALK
ऑनलाइन पहुंच:http://www.karger.com/Article/FullText/366516
टैग: टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन